Clinton proposes 18% increase in FDA funding
This article was originally published in Clinica
The FDA's resource problems may be easing slightly. President Clinton's federal budget proposal for 2000 includes a hefty 18% increase which would be the largest addition to the agency's resources in its history. A substantial portion of that increase - $95.5 million - would be used to help pay for implementing the FDA Modernization Act of 1997 (FDAMA) in the area of injury reporting, product reviews and inspections.
You may also be interested in...
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.